设为首页 加入收藏

TOP

NEULASTA ( pegfilgrastim ) injection(三十二)
2016-01-24 05:49:20 来源: 作者: 【 】 浏览:12631次 评论:0
;
pegfilgrastim kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:55513-192
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:55513-192-01 1 in 1 CARTON; Type 9: Other Type of Part 3 Combination Product (e.g., Drug/Device/Biological Product)  
 
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 SYRINGE 0.6 mL
 
Part 1 of 1
NEULASTA 
pegfilgrastim injection
 
Product Information

Route of Administration SUBCUTANEOUS DEA Schedule     
 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEGFILGRASTIM (UNII: 3A58010674) (PEGFILGRASTIM - UNII:3A58010674) PEGFILGRASTIM 6 mg  in 0.6 mL
Inactive Ingredients
Ingredient Name Strength
ACETIC ACID (UNII: Q40Q9N063P) 0.35 mg  in 0.6 mL
POLYSORBATE 20 (UNII: 7T1F30V5YH) 0.02 mg  in 0.6 mL
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITOL (UNII: 506T60A25R) 30.0 mg  in 0.6 mL
WATER (UNII: 059QF0KO0R)  
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1  0.6 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)  
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125031 04/01/2002 
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125031 04/01/2002 
NEULASTA 
pegfilgrastim injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:55513-190
Route of Administration SUBCUTANEOUS DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
PEGFILGRASTIM (UNII: 3A58010674) (PEGFILGRASTIM - UNII:3A58010674) PEGFILGRASTIM 6 mg  in 0.6 mL
 
Inactive Ingredients
Ingredient Name Strength
ACETIC ACID (UNII: Q40Q9N063P) 0.35 mg  in 0.6 mL
POLYSORBATE 20 (UNII: 7T1F30V5YH) 0.02 mg  in 0.6 mL
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
SORBITOL (UNII: 506T60A25R) 30.0 mg  in 0.6 mL
WATER (UNII: 059QF0KO0R)  
 
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:55513-190-01 1 in 1 CARTON  
1  0.6 mL in 1 SYRINGE; Type 3: Prefilled Biologic Delivery Device/System (syringe, patch, etc.)  
 
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA125031 04/01/2002 
 
Labeler - Amgen Inc (039976196) 
Establishment
Name Address ID/FEI Business Operations
Amgen Manufacturing Ltd  785800020 ANALYSIS(55513-190, 55513-192) , LABEL(55513-192, 55513-190) , MANUFACTURE(55513-190, 55513-192) , PACK(55513-192, 55513-190
 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 29 30 31 32 下一页 尾页 32/32/32
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇ZARXIO(filgrastim-sndz) injecti.. 下一篇STALEVO (carbidopa, levodopa an..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位